News
Washington Examiner: CMS names 10 drugs under new price controls, but advocates warn of 'cruel' side effects
The Centers for Medicare and Medicaid Services released on Tuesday the list of 10 medications that will be part of the price-setting Drug Price Negotiation Program through the Inflation Reduction Act, affecting an estimated 8.2 million patients with a range of illnesses, including heart failure, blood clots, diabetes, and arthritis.
SFS Statement on CMS's New Drug Price Negotiation Talks
The nonpartisan patient advocacy group, Survivors for Solutions, started by John “CZ” Czwartacki, a patient who has managed his MS for 30 years, provided a patient perspective on CMS’s drug price negotiation program talks this fall.
SFS Statement on CMS's Alzheimer's Drug Coverage Plan
The nonpartisan patient advocacy group, Survivors for Solutions, started by John “CZ” Czwartacki, a patient who has managed his MS for 30 years, provided a patient perspective on CMS’s new coverage plan for Alzheimer’s drugs:
Minnesota’s Ill-conceived Prescription Drug Affordability Board
Minnesota is considering instituting an ill-conceived Prescription Drug Affordability Board (PDAB) over its state health care system, and the recent news of a state lawsuit against CVS brings more cause for concern.
Inside Sources: CMS Charges Ahead with Drug Price Controls Despite Patient Concerns
Do you know that nightmare where you see someone about to get hurt or worse, but they don’t see the obvious danger? And your anguished pleas go unheard?
You wake from this frustrating helplessness, relieved it was just a dream.
Except, right now, I’m not waking up.